Health Systems and Policy Contexts of Medical Oxygen

NCT06169514 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1

Last updated 2026-02-06

No results posted yet for this study

Summary

This is a mixed-methods program evaluation from a health systems and policy perspective, involving (i) stakeholder analysis, (ii) policy-implementation gap analysis, and (iii) comparative country case studies. This study aims to understand how national oxygen strategies achieve impact at national, and subnational level, across country contexts, at what cost.

The the investigators seek to:

1. Involve policymakers, implementers (including private sector), and medical oxygen users in identifying challenges and understanding potential solutions to medical oxygen access;
2. Generate new data on how medical oxygen systems work and can be improved from multiple perspectives;
3. Draw lessons on medical oxygen that can directly inform national and global practice and policy.

This study will be conducted in 6 of the 9 countries participating in the Clinton Health Access Initiative (CHAI) led Medical Oxygen Implementation (MOXY) program (Uganda, Nigeria, Rwanda, Liberia, Lao PDR, Cambodia).

Key informants will be selected representing government, non-governmental agencies, professional associations, private sector, and civil society. This study will be completed over 4 years, with timelines varying between country study sites.

Conditions

Interventions

OTHER

No intervention

No intervention

Sponsors & Collaborators

  • University of Ibadan

    collaborator OTHER
  • University of Health Sciences, Lao People's Democratic Republic (PDR)

    collaborator UNKNOWN
  • University of Health Sciences, Cambodia

    collaborator UNKNOWN
  • Makerere University

    collaborator OTHER
  • Ministry of Health, Liberia

    collaborator OTHER
  • Ministry of Health, Rwanda

    collaborator OTHER_GOV
  • Karolinska Institutet

    collaborator OTHER
  • Murdoch Childrens Research Institute

    lead OTHER

Principal Investigators

  • Hamish Graham, PhD · Murdoch Childrens Research Institute

  • Carina King, PhD · Karolinska Institutet

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-07-31
Primary Completion
2027-12-31
Completion
2027-12-31

Countries

  • Cambodia
  • Laos
  • Liberia
  • Nigeria
  • Rwanda
  • Uganda

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06169514 on ClinicalTrials.gov